Laura Seestaller‐Wehr

The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4

Li Liu, Patrick A. Mayes, Stephen D. Eastman et al. · Clinical Cancer Research · 2015 · 440 citations

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra et al. · PLoS ONE · 2018 · 197 citations · Full text

Unique Tumor-immune Infiltrate, Novel Anti-cancer Immunotherapies, Immunology +17

Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma

Lydia Lee, Danton Bounds, Jennifer C. Paterson et al. · British Journal of Haematology · 2016 · 196 citations · Full text

Immunology, Pathology, Immunotherapy +16

The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells

Julia Billiard, Deana S. Way, Laura Seestaller‐Wehr et al. · Molecular Endocrinology · 2004 · 164 citations · Full text

Mechanobiology, Sclerostin, Developmental Biology +14

A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation

Peter V.N. Bodine, Barbara Stauffer, Helga Ponce‐de‐Leon et al. · Bone · 2009 · 124 citations

Sclerostin, Signal Transduction, Bone Morphogenic Protein +12